The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 16 2019 for K. Nityananda Reddy
16-Nov-2019
Download PDF
Aurobindo Pharma
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 16 2019 for K. Nityananda Reddy